167 related articles for article (PubMed ID: 36559787)
21. Molecularly Imprinted Nanoparticles (NanoMIPs) Selective for Proteins: Optimization of a Protocol for Solid-Phase Synthesis Using Automatic Chemical Reactor.
Cáceres C; Moczko E; Basozabal I; Guerreiro A; Piletsky S
Polymers (Basel); 2021 Jan; 13(3):. PubMed ID: 33498149
[TBL] [Abstract][Full Text] [Related]
22. A comparison of the performance of molecularly imprinted polymer nanoparticles for small molecule targets and antibodies in the ELISA format.
Smolinska-Kempisty K; Guerreiro A; Canfarotta F; Cáceres C; Whitcombe MJ; Piletsky S
Sci Rep; 2016 Nov; 6():37638. PubMed ID: 27883023
[TBL] [Abstract][Full Text] [Related]
23. Determination of sitagliptin in human plasma using a smart electrochemical sensor based on electroactive molecularly imprinted nanoparticles.
Haq I; Alanazi K; Czulak J; Di Masi S; Piletska E; Mujahid A; Hussain T; Piletsky SA; Garcia-Cruz A
Nanoscale Adv; 2021 Jul; 3(14):4276-4285. PubMed ID: 36132843
[TBL] [Abstract][Full Text] [Related]
24. Analysis of luteinizing hormone (LH): Validation of a commercial ELISA kit for LH analysis and quantification in doping control samples.
Mäkelä R; Leinonen A; Suominen T
Drug Test Anal; 2020 Feb; 12(2):239-246. PubMed ID: 31655497
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the analysis of beta-blockers by different techniques.
Pujos E; Cren-Olivé C; Paisse O; Flament-Waton MM; Grenier-Loustalot MF
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Dec; 877(31):4007-14. PubMed ID: 19879818
[TBL] [Abstract][Full Text] [Related]
26. Thermal Detection of Cardiac Biomarkers Heart-Fatty Acid Binding Protein and ST2 Using a Molecularly Imprinted Nanoparticle-Based Multiplex Sensor Platform.
Crapnell RD; Canfarotta F; Czulak J; Johnson R; Betlem K; Mecozzi F; Down MP; Eersels K; van Grinsven B; Cleij TJ; Law R; Banks CE; Peeters M
ACS Sens; 2019 Oct; 4(10):2838-2845. PubMed ID: 31571480
[TBL] [Abstract][Full Text] [Related]
27. Detection of selective androgen receptor modulators (SARMs) in serum using a molecularly imprinted nanoparticle surface plasmon resonance sensor.
Henderson A; Sullivan MV; Hand RA; Turner NW
J Mater Chem B; 2022 Sep; 10(35):6792-6799. PubMed ID: 35678703
[TBL] [Abstract][Full Text] [Related]
28. Assessing the In Vivo Biocompatibility of Molecularly Imprinted Polymer Nanoparticles.
Kassem S; Piletsky SS; Yesilkaya H; Gazioglu O; Habtom M; Canfarotta F; Piletska E; Spivey AC; Aboagye EO; Piletsky SA
Polymers (Basel); 2022 Oct; 14(21):. PubMed ID: 36365575
[TBL] [Abstract][Full Text] [Related]
29. Determination of Fumonisin B1 in maize using molecularly imprinted polymer nanoparticles-based assay.
Munawar H; Safaryan AHM; De Girolamo A; Garcia-Cruz A; Marote P; Karim K; Lippolis V; Pascale M; Piletsky SA
Food Chem; 2019 Nov; 298():125044. PubMed ID: 31260971
[TBL] [Abstract][Full Text] [Related]
30. [Effect of 2 beta-blockers on arterial hypertension during pregnancy. Results of a prospective study on 56 pregnant hypertensive women treated with atenolol and labetalol].
Gérard J; Blazquez G; Lardoux H; Beauséjour B; Faurie C; Rousset D; Flouvat B
J Gynecol Obstet Biol Reprod (Paris); 1983; 12(8):891-900. PubMed ID: 6672083
[TBL] [Abstract][Full Text] [Related]
31. N,N-dimethyl-2-phenylpropan-1-amine quantification in urine: application to excretion study following single oral dietary supplement dose.
Wójtowicz M; Jarek A; Chajewska K; Kwiatkowska D
Anal Bioanal Chem; 2016 Jul; 408(18):5041-7. PubMed ID: 27178556
[TBL] [Abstract][Full Text] [Related]
32. Direct doping analysis of beta-blocker drugs from urinary samples by on-line molecularly imprinted solid-phase extraction coupled to liquid chromatography/mass spectrometry.
Santos MG; Tavares IM; Boralli VB; Figueiredo EC
Analyst; 2015 Apr; 140(8):2696-703. PubMed ID: 25679017
[TBL] [Abstract][Full Text] [Related]
33. Ultrasensitive detection of endotoxins using computationally designed nanoMIPs.
Altintas Z; Abdin MJ; Tothill AM; Karim K; Tothill IE
Anal Chim Acta; 2016 Sep; 935():239-48. PubMed ID: 27543033
[TBL] [Abstract][Full Text] [Related]
34. A simple and rapid ESI-LC-MS/MS method for simultaneous screening of doping agents in urine samples.
Reddy IM; Beotra A; Jain S; Ahi S
Indian J Pharmacol; 2009 Apr; 41(2):80-6. PubMed ID: 20336223
[TBL] [Abstract][Full Text] [Related]
35. A Plasmonic Biosensor Based on Light-Diffusing Fibers Functionalized with Molecularly Imprinted Nanoparticles for Ultralow Sensing of Proteins.
Arcadio F; Seggio M; Del Prete D; Buonanno G; Mendes J; Coelho LCC; Jorge PAS; Zeni L; Bossi AM; Cennamo N
Nanomaterials (Basel); 2022 Apr; 12(9):. PubMed ID: 35564109
[TBL] [Abstract][Full Text] [Related]
36. Retention and selectivity of basic drugs on solid-phase extraction sorbents: application to direct determination of β-blockers in urine.
Boonjob W; Sklenářová H; Lara FJ; García-Campaña AM; Solich P
Anal Bioanal Chem; 2014 Jul; 406(17):4207-15. PubMed ID: 24788887
[TBL] [Abstract][Full Text] [Related]
37. The use of performance-enhancing substances (doping) by athletes in Saudi Arabia.
Al Ghobain M
J Family Community Med; 2017; 24(3):151-155. PubMed ID: 28932159
[TBL] [Abstract][Full Text] [Related]
38. Monitoring 2-phenylethanamine and 2-(3-hydroxyphenyl)acetamide sulfate in doping controls.
Sigmund G; Dib J; Tretzel L; Piper T; Bosse C; Schänzer W; Thevis M
Drug Test Anal; 2015; 7(11-12):1057-62. PubMed ID: 26481102
[TBL] [Abstract][Full Text] [Related]
39. [Preparation of molecularly imprinted polymers based on covalent organic frameworks and their application to selective recognition of trace norfloxacin in milk].
Xie Y; Zhang Y; Shi H; Wu Z; Yu X; Zhang C; Feng S
Se Pu; 2022 Jan; 40(1):1-9. PubMed ID: 34985210
[TBL] [Abstract][Full Text] [Related]
40. Molecularly Imprinted Nanoparticles for Biomedical Applications.
Zhang H
Adv Mater; 2020 Jan; 32(3):e1806328. PubMed ID: 31090976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
